290 related articles for article (PubMed ID: 8262560)
21. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
22. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
23. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
Li X; Yang X; Jiang Y; Liu J
Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
[TBL] [Abstract][Full Text] [Related]
24. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
Schirmbeck R; Böhm W; Reimann J
J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
[TBL] [Abstract][Full Text] [Related]
25. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
Milich DR; Chisari FV
J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
[TBL] [Abstract][Full Text] [Related]
26. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
Wettstein PJ; Colombo MP
J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
28. Development of highly sensitive Bicistronic vector based non-radioactive antigen-specific cytotoxicity assay.
Gupta P; Tayal R; Durgapal H; Rath S; Acharya SK; Panda SK
J Immunol Methods; 2009 Sep; 349(1-2):28-37. PubMed ID: 19682994
[TBL] [Abstract][Full Text] [Related]
29. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets.
Wang W; Golding B
Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814
[TBL] [Abstract][Full Text] [Related]
30. The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes.
Schick B; Berke G
Immunology; 1990 Nov; 71(3):428-33. PubMed ID: 2269479
[TBL] [Abstract][Full Text] [Related]
31. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
32. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
[TBL] [Abstract][Full Text] [Related]
33. MHC-restricted cytotoxic response of chicken T cells: expression, augmentation, and clonal characterization.
Maccubbin DL; Schierman LW
J Immunol; 1986 Jan; 136(1):12-6. PubMed ID: 2415611
[TBL] [Abstract][Full Text] [Related]
34. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
[TBL] [Abstract][Full Text] [Related]
35. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
[TBL] [Abstract][Full Text] [Related]
36. [Immunoprotection role of a hepatitis B virus DNA vaccine responsible to BAlb/c mice].
He F; Tang H; Liu L; Zhao LS; Liu C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):613-6. PubMed ID: 17718423
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
38. Cross-reactivity patterns of influenza-specific cytotoxic T lymphocytes from H-2Kb mutant mice.
Hurwitz JL; Wettstein PJ; Bennink JR; Doherty PC
J Immunol; 1983 Jul; 131(1):471-4. PubMed ID: 6190923
[TBL] [Abstract][Full Text] [Related]
39. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
40. H-2 Kd-restricted hepatitis B virus-derived epitope whose specific CD8+ T lymphocytes can produce gamma interferon without cytotoxicity.
Chen A; Wang L; Zhang J; Zou L; Jia Z; Zhou W; Wan Y; Wu Y
J Virol; 2005 May; 79(9):5568-76. PubMed ID: 15827171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]